Manabu Makinodan, MD, PhD

Department of Psychiatry, Fujita Health University School of Medicine, Aichi, Japan; Department of Psychiatry, Nara Medical University School of Medicine, Nara, Japan

JCP
BI 1358894 in Borderline Personality Disorder
Original Research

January 13, 2025

Although the primary endpoint was not met, BI 1358894 was well-tolerated with no increase in self-harm or suicidality.
, , , et al

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe